September 21, 2017
How concussions as a teenager may be linked to MS as an adult….
September 20, 2017
Vitamin D may be critical….
September 16, 2017
Understanding Progression in MS is a booklet supported by an educational grant from Sanofi Genzyme….
September 12, 2007
The role gut microbes play….
September 7, 2017
There may be a link between a childhood virus and developing MS as an adult….
September 2, 2017
Understand MS relapses, learn about treatments and prepare for the unexpected flare-ups in disease activity….
August 24, 2017
Are we close to a cure?….
August 23, 2017
Rules and suggestions for diagnosing multiple sclerosis….
August 20, 2017
Artists talk about how their neurologic conditions affect their art….
August 17, 2017
Research uncovers a gut microbe that has the potential to treat autoimmune diseases….
August 13, 2017
Does getting sick spark a relapse?
August 3, 2017
August 1, 2017
Resistance training may reduce brain atrophy….
July 31, 2017
Does “The Swank” diet help reduce the frequency of flares and lessen the severity of symptoms?….
July 20, 2017
Breast-feeding may reduce the mother’s MS risk….
July 19, 2017
The loss of smell can impact many with MS….
July 17, 2017
Important updates from two recent MS conventions….
July 13, 2017
The way in which patients with multiple sclerosis answer questionnaires could help to predict their survival rate…
July 6, 2017
A readily available, over-the-counter antioxidant may help to slow the progression of MS….
May 30, 2017
The 2017 edition of MSAA’s MS Research Update provides a comprehensive overview of the study results on many experimental treatments currently under investigation…
May 18, 2017
It is commonly thought that in MS, the loss of axons (nerve fibres) contributes to the chronic disability, however…..
May 10, 2017
Alemtuzumab improves long-term clinical and radiological outcomes in black patients….
April 19, 2017
Ask the Doctor, Evaluating the Hereditary Risk of MS
April 17, 2017
Stories to Inspire, Family Comes First….
April 15, 2017
MRI Access Fund Now Fully Restored….
March 30, 2017
New gene interaction associated with increased MS risk….
March 29, 2017
Researchers say that they may have found a way to restore myelin formation….
March 28, 2017
The humanized monoclonal antibody ocrelizumab became the first drug to receive approval from the Food and Drug Administration for the treatment of primary progressive multiple sclerosis….
March 2, 2017
Weekly videos for the month of March for MS Awareness Month….
March 1, 2017
New technology improves cognition….
February 23, 2017
Stem cell transplantation may halt disease progression….
February 13, 2017
Individuals with Medicare and private health insurance who cannot meet their co-insurance balance are now eligible to apply for funding assistance for a cranial magnetic resonance imaging (MRI) exam….
February 9, 2017
Diagnosing MS can sometimes be difficult because there isn’t one single definitive test for the disease. Therefore, if a doctor suspects a person has MS, they may be referred to a neurologist who specializes in caring for people with MS….
January 26, 2017
Different types of MS and symptoms to look for…
January 25, 2017
Severe side effects have been found…..
January 24, 2017
The tests used to diagnosis MS….
January 11, 2017
Brain may continue to grow, or at least one part may…
December 14, 2016
Before scheduling an operation, consider these important questions…
December 14, 2016
Going on Record: Patients have a right to their medical records but often don’t know how to access them…
December 6, 2016
Stem Cell Reality: Desperate patients are vulnerable to the promise of stem cell therapy—most of it unproven…
November 25, 2016
Sexual Healing: A neurologic diagnosis doesn’t mean the end of intimacy….
October 12, 2016
Information about stem cell treatment…
September 9, 2016
The cost of multiple sclerosis (MS) care is rising due to escalating prices of disease-modifying therapies (DMTs) over the last several years. Insurers have responded by passing some of the cost to the patient in the form of denying costly therapies or limiting payment, which may have a negative effect on MS care.
August 31, 2016
A Phase III study with siponimod, an experimental oral treatment for MS, is showing positive results for individuals with secondary-progressive multiple sclerosis.
August 22, 2016
Fatigue is one of the most disabling side effects in people with multiple sclerosis. Learn more by clicking the link below…
July 21, 2016
Two vital conferences providing the latest information and research on multiple sclerosis (MS) take place in the spring of each year….
July 5, 2016
The MS MRI fund has returned!
MSAA has temporarily reopened our longstanding and highly-requested MRI Access Fund Program. Through recent support from Teva Neuroscience, MSAA has been able to lift the program’s six-month suspension and resume processing MRI requests for MS diagnostic and follow-up exams until funds are exhausted.
MSAA will only accept the updated 2016 MRI Access Fund application, which requires the submission of documented income and insurance information. As with before, applications will be processed on a first-come, first-serve basis; no emergency situations apply; and no reimbursements provided for previous MRIs.
MSAA is extremely pleased to resume this critically important service to the MS community while we continue to work on securing additional grants and restoring the MRI Access Fund to its full level of service. If you have any questions, please call (800) 532-7667, ext. 120.
July 4, 2016
Genentech today announced that its Biologics License Application for ocrelizumab, marketed as Ocrevus™, has been accepted for review by the US FDA.
July 1, 2016
A new study provides further confirmation of a link between obesity and MS.
June 15, 2016
Spasticity, which is an involuntary tightness or stiffness of the muscles, is one of the most common symptoms of multiple sclerosis….
June 2, 2016
This monoclonal antibody is self-administered subcutaneously (under-the-skin) once per month and has been shown to reduce the number of relapses….
May 17, 2016
Epidemiological studies indicate that vitamin D might be particularly important for people with MS…
May 16, 2016
Patients with multiple sclerosis (MS) who are treated with mitoxantrone may have a greater risk of colon cancer and acute myeloid leukemia…
May 12, 2016
Using pre-clinical models for multiple sclerosis (MS) and samples from MS patients, the team found evidence that changes in diet and gut flora may influence astrocytes in the brain…
May 9, 2016
The editorial staff of Neurology Reviews has collected its on-site reporting from the 68th Annual Meeting of the American Academy of Neurology and here’s the online digital edition.
April 15, 2016
A common antihistamine available over the counter has shown evidence of remyelination in patients with MS in a double-blind, placebo-controlled trial…
April 14, 2016
April 13, 2016
A group of T2 weighted hyperintensities that disseminate in what is called a “punctate pattern” (PP) may directly precede the appearance of progressive multifocal leukoencephalopathy (PML) lesions…
April 12, 2016
Certain MS treatment may be linked to shingles…
April 11, 2016
Smoking may be linked to abnormalities in the brain…
March 31, 2016
See how stem cells are used in MS treatment…
March 30, 2016
Social Security Inspector General Patrick P. O’Carroll is warning citizens to be aware of phone calls from unknown people who claim to have information about a citizen’s application for disability benefits…
March 20, 2016
To view the latest in MS news from Neurology Review visit:
March 15, 2016
The latest innovations and late-phase studies in the drug pipeline for Multiple Sclerosis….
March 14, 2016
The antidiabetic agents metformin and pioglitazone appear to have beneficial anti-inflammatory effects in patients with comorbid multiple sclerosis (MS) and metabolic syndrome…
February 17, 2016
Andrew Liebig of Wasilla has an amazing all-terrian motorized chair that may be available to other Alaskans with MS. See how a special program may help you or someone you know…
February 16, 2016
Breakthrough Therapy Designation” for ocrelizumab, an experimental medication presently under investigation for the treatment of primary-progressive multiple sclerosis
January 6, 2016
T-cell biomarker not viable for detecting PML…
December 27, 2015
Visit the MS Foundation’s newsletter…
December 16, 2015
Death of nerve cells that make myelin may trigger an autoimmune response…
December 15, 2015
Study of neurological disorders of Gulf War vets…
December 2, 2015
Estrogen has been found to help prevent relapses…
December 1, 2015
Growing nerve cells may lead to transplants…
November 24, 2015
Highlights from the Joint ACTRIMS-ECTRIMS Meeting…
November 16, 2015
The benefits of exercise for those with MS…
September 16, 2015
Smoking after diagnosis may worsen disease faster…
September 15, 2015
MS changes with less daylight…
September 9, 2015
The benefits from breastfeeding…
September 8, 2015
How animal cells may help…
September 3, 2015
Letter from a mother with MS to a son who doesn’t understand…
September 3, 2015
Brother struggle showed bravery…
September 2, 2015
What may lead to increasing disability for some MS patients…
September 1, 2015
Vitamin D levels linked to MS risk…
August 24, 2015
Stem cell update for MS…
August 23, 2015
Wellness moves to the forefront at latest meeting…
August 15, 2015
New iOS and Android app from MSAA to help manage your MS and directly link to your physician.
July 23, 2015
Salt may worsen MS symptoms…
June 9, 2015
Highlights from the American Academy of Neurology’s 67th Annual Meeting that took place in Washington, DC from April 18th-25th….
May 27, 2015
“MS and the Gut”
May 20, 2015
Genetic variant predicts likelihood of patient’s response to treatment….
Researchers have found what may be a cause of the disease….
May 18, 2015
Study links processed foods to autoimmune diseases….
Major progressive MS trial….
May 6, 2015
Scientists find a possible new treatment for autoimmune disorders….
April 29, 2015
Once daily MS pill (Gilenya) reaches new treatment goal….
Plegridy three-year data supports long term safeety and efficacy in MS patients….
Effect of Lemtrada on slowing brain atrophy and MRI lesion activity….
Drug prices to treat MS soar….
April 17, 2015
FDA approves Glatopa™ (glatiramer acetate injection) for the treatment of individuals with relapsing forms of multiple sclerosis….
April 13, 2015
Menarche, Menstruation, Menopause, and MS is one video. Second is Pregnancy and the MS Patient: Pre-Pregnancy through Post-Partum
April 12, 2015
A comprehensive tutorial reference detailing our current understanding of Multiple Sclerosis
April 10, 2015
Are stem cell transplants superior to Mitoxantrone for severe MS?
No evidence of disease activity may have predictive value….
April 1, 2015
Major new study in Great Britain on how people with MS can overcome problems with attention and memory….
March 12, 2015
Copaxone lipoatrophy more common than reported…..
Can exercise help?…..
March 11, 2015
The invisible difficulties…..
Article on genetic risk factors…..
Approved drug is a myelin-maker…..
March 10, 2015
February 19, 2015
MSAA offers an extensive library of on-demand video programming, webcasts, professionally monitored chat rooms, and additional interactive communication features that bring knowledge and empowerment right into the privacy and comfort of a person’s home.
February 18, 2015
Stem Cell transplants may be more effective than drugs for people with severe cases of MS, according to a new study…
February 12, 2015
The full pathological progress of multiple sclerosis has been documented…
February 4, 2015
IMPORTANT news about MSAA merging MRI Programs into the MRI Access Fund
January 15, 2015
Collaboration aims to reduce neurodegeneration
January 7, 2015
Report on remission in MS patients 3 years after stem cell transplant……
December 17. 2014
Researchers will track the lives of people with multiple sclerosis (MS) in unprecedented detail in a project to improve the evaluation of treatments.
December 10, 2014
UC Riverside-led mouse study shows the ligand indazole chloride improves motor function, imparting therapeutic benefits even when treatment is initiated at the peak of disease.
In a new study published in the journal Frontiers in Neurology, a team of researchers led by the University of Surrey, have identified a rogue protein in multiple sclerosis, which attacks the body’s central nervous system. Researchers believe this finding could pave the way for better understanding of multiple sclerosis and new treatments against neurodegenerative diseases.
November 16, 2014
Lemtrada™ Receives FDA Approval for Relapsing Forms of MS – Please see MSAA’s online news article for more information!
If links are disabled in this email, please copy and paste the following address into your web browser to view the full article:
November 5, 2014
New tool helps make sense of previous genetic data on multiple sclerosis:
October 30, 2014
August 19, 2014
Plegridy™ Approved for
Relapsing Forms of MS
On August 15, 2014, Biogen Idec announced that the United States Food and Drug Administration (FDA) approved Plegridy™ (
As with all of the approved DMTs for MS, Plegridy is not a cure, but does slow MS disease activity. It reduces the annual relapse rate (ARR) as well as the number and size of brain lesions (areas of inflammation) as seen on magnetic resonance imaging (MRI) scans. Additionally, Plegridy reduced the risk of 12-week confirmed disability progression, as measured by the Expanded Disability Status Scale (EDSS).
If links are disabled in this email – to read the full article, copy and paste the following into your web browser:
August 5, 2014
Exclusive Use of Alternative Medicine as a Positive Choice: A Qualitative Study of Treatment Assumptions Among People with Multiple Sclerosis in Denmark
A Pooled Analysis of Two Phase 3 Clinical Trials of Dalfampridine in Patients with Multiple Sclerosis
Andrew D. Goodman, Theodore R. Brown, Randall T. Schapiro, Michael Klingler, Ron Cohen and Andrew R. Blight
Effects of Functional Electrical Stimulation on Gait Function and Quality of Life for People with Multiple Sclerosis on Ampyra
R. Philip Kinkel, Genevieve Laforet and Xiaojun You
Informing the Children When a Parent Is Diagnosed with Multiple Sclerosis
August 1, 2014
The Disability Treaty
will be back!
You and thousands of other advocates around the country have been working tirelessly towards ratification – we salute your hard work on this crucial issue!
Though a floor time was not possible before the August recess, we look forward to new opportunities in September!
IT’S NOT OVER UNTIL IT’S OVER!
In the Foreign Relations Committee, RepublicanSenator John Barrasso of Wyoming included three amendments:
* An understanding that the CRPD will NOT affect the rights of parents to homeschool their children.
* An understanding that nothing in Article 7 regarding children with disabilities requires changes in U.S. law
* An understanding of the limited scope of the CRPD committee’s authority
These address the concerns of the opposition moving forward!
We’ll be back to you soon with more information!
Visit our citizen action portal,www.disabilitytreaty.org to stay informed and take action!